1. Home
  2. DYN vs ASTE Comparison

DYN vs ASTE Comparison

Compare DYN & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • ASTE
  • Stock Information
  • Founded
  • DYN 1984
  • ASTE 1972
  • Country
  • DYN United States
  • ASTE United States
  • Employees
  • DYN N/A
  • ASTE N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • ASTE Construction/Ag Equipment/Trucks
  • Sector
  • DYN Health Care
  • ASTE Industrials
  • Exchange
  • DYN Nasdaq
  • ASTE Nasdaq
  • Market Cap
  • DYN 848.8M
  • ASTE 777.8M
  • IPO Year
  • DYN 2020
  • ASTE N/A
  • Fundamental
  • Price
  • DYN $10.78
  • ASTE $34.28
  • Analyst Decision
  • DYN Strong Buy
  • ASTE Hold
  • Analyst Count
  • DYN 12
  • ASTE 2
  • Target Price
  • DYN $47.73
  • ASTE $39.00
  • AVG Volume (30 Days)
  • DYN 2.8M
  • ASTE 138.0K
  • Earning Date
  • DYN 05-05-2025
  • ASTE 04-29-2025
  • Dividend Yield
  • DYN N/A
  • ASTE 1.51%
  • EPS Growth
  • DYN N/A
  • ASTE N/A
  • EPS
  • DYN N/A
  • ASTE 0.19
  • Revenue
  • DYN N/A
  • ASTE $1,305,100,000.00
  • Revenue This Year
  • DYN N/A
  • ASTE $6.05
  • Revenue Next Year
  • DYN N/A
  • ASTE $4.34
  • P/E Ratio
  • DYN N/A
  • ASTE $182.13
  • Revenue Growth
  • DYN N/A
  • ASTE N/A
  • 52 Week Low
  • DYN $6.36
  • ASTE $28.46
  • 52 Week High
  • DYN $47.45
  • ASTE $44.03
  • Technical
  • Relative Strength Index (RSI)
  • DYN 57.30
  • ASTE 51.30
  • Support Level
  • DYN $7.38
  • ASTE $32.52
  • Resistance Level
  • DYN $8.01
  • ASTE $35.27
  • Average True Range (ATR)
  • DYN 0.91
  • ASTE 1.92
  • MACD
  • DYN 0.44
  • ASTE 0.12
  • Stochastic Oscillator
  • DYN 92.47
  • ASTE 75.90

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: